19 min listen
Episode 220: ASCO GU 2023: Discussing PARPi for CRPC with Michael Morris, MD
FromThe Uromigos
ratings:
Length:
25 minutes
Released:
Feb 17, 2023
Format:
Podcast episode
Description
The Uromigos met with Michael Morris, MD while at the 2023 ASCO GU Cancers Symposium to discuss PARP inhibition for castration-resistant prostate cancer and the differing opinions on how and when it should be utilized. Dr. Morris is a prostate cancer specialist and researcher, and the Prostate Cancer Section Head at Memorial Sloan Kettering Cancer Center.
Released:
Feb 17, 2023
Format:
Podcast episode
Titles in the series (100)
Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials by The Uromigos